John King-Underwood
41Patents
12h-index
42Co-inventors
77Inventor score
Filing activity: Dec 23, 2004 → Sep 24, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8299073B2 | P38 MAP kinase inhibitors | Chemistry; Metallurgy | 46 | Active |
| US8299074B2 | P38 MAP kinase inhibitors | Chemistry; Metallurgy | 44 | Active |
| US8293748B2 | p38 MAP kinase inhibitors | Chemistry; Metallurgy | 44 | Active |
| US8293771B2 | p38 MAP kinase inhibitors | Human Necessities | 44 | Active |
| US8642773B2 | P38MAP kinase inhibitor | Human Necessities | 42 | Active |
| US8618140B2 | P38 MAP kinase inhibitors | Chemistry; Metallurgy | 39 | Active |
| US9108950B2 | 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitors | Emerging Cross-Sectional Technologies | 34 | Active |
| US9249125B2 | Pyrazole derivatives as p38 MAP inhibitors | Chemistry; Metallurgy | 29 | Active |
| US9024041B2 | P38 MAP kinase inhibitors | Chemistry; Metallurgy | 27 | Active |
| US8975285B2 | P38 MAP kinase inhibitors | Chemistry; Metallurgy | 26 | Active |
| US9447076B2 | Inhibitor of p38 map kinase | Chemistry; Metallurgy | 16 | Active |
| US9624196B2 | Inhibitor of p38 MAP kinase | Chemistry; Metallurgy | 15 | Active |
| US9475796B2 | 1-pyrazolyl-3-((4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors | Chemistry; Metallurgy | 11 | Active |
| US9701670B2 | Pyrazolyl-ureas as kinase inhibitors | Chemistry; Metallurgy | 10 | Active |
| US9260410B2 | P38 MAP kinase inhibitors | Human Necessities | 7 | Active |
| US8207147B2 | Heterocyclic derivatives as GPCR receptor agonists | Chemistry; Metallurgy | 7 | Active |
| US9242960B2 | P38MAP kinase inhibitors | Human Necessities | 6 | Active |
| US8741909B2 | PI3 kinase inhibitors | Human Necessities | 5 | Active |
| US10266519B2 | 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors | Emerging Cross-Sectional Technologies | 3 | Active |
| US9850231B2 | 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors | Emerging Cross-Sectional Technologies | 3 | Active |
| US9724347B2 | 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10238658B2 | 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9771354B2 | Pyrazole p38 map kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9340545B2 | Quinazolin-4 (3H)—one derivatives used as P13 kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10294216B2 | Pyrazolyl ureas as kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.